Gemcitabine-related pulmonary toxicity
- PMID: 11901447
- DOI: 10.4414/smw.2002.09893
Gemcitabine-related pulmonary toxicity
Abstract
Background: Gemcitabine is an increasingly used and generally well tolerated anticancer drug. Rarely, it leads to potentially fatal pulmonary toxicity.
Case descriptions and results: We describe the clinical features of 5 patients with gemcitabine-related pulmonary toxicity. Due to early diagnosis, prompt discontinuation of the drug, and treatment with steroids, toxicity was reversible in all cases.
Conclusion: Early recognition of gemcitabine-related pulmonary toxicity is mandatory.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical